LGALS3 and glioblastoma: The CHI3L1/Gal-3 pathway facilitates GBM evasion from immune surveillance by leveraging the CHI3L1/Gal-3 protein complex capacity to activate the AKT/mTOR-mediated transcriptional regulatory network (involving NF-κB and CEBPβ) [132].